Preoperative staging of carcinoma of the bronchus: can computed tomographic scanning reliably identify stage III tumours?

P G White, H Adams, M D Crane, E G Butchart

Department of Radiology, Llandough Hospital, NHS Trust, Penarth, South Glamorgan, UK.

BACKGROUND--The aim of preoperative computed tomographic (CT) assessment of patients with carcinoma of the bronchus is to stage the tumour accurately, and forewarn the surgeon of any possible local extrapulmonary extension of tumour in patients considered to have potentially resectable disease. The ability of CT scanning to differentiate between conventionally resectable lung cancer (TNM stages I and II), locally advanced but resectable lung cancer (TNM stage IIIa), and locally advanced but unresectable lung cancer (TNM stage IIIb) was determined in a group of patients accepted for surgery. METHODS--Computed tomographic scans of 110 patients who underwent thoracotomy for intended resection of carcinoma of the bronchus, including 52 cases with stage III and 58 cases with stage I or II disease, were reviewed and the CT features and radiological interpretations correlated with the surgical and pathological findings. RESULTS--Thirteen CT scans were judged not to have been of diagnostic quality: of the remaining 97 cases 45 had stage III lung cancer, of whom 30 had successful resections, and 52 had stage I or stage II tumours. There was no difference in the frequencies of CT observations--including contiguity of tumour and mediastinum or chest wall, apparent mediastinal or chest wall invasion, proximity of tumour to the carina, mediastinal nodal enlargement, pulmonary collapse or consolidation and pleural effusion--in patients with stage I/II disease and patients with stage III disease. Similar results were found when the same observations were compared in all patients with resected disease and those with unresectable tumour. Sensitivity and specificity of CT was 27% and 96% respectively for tumour unresectability, 50% and 89% for mediastinal invasion, 14% and 99% for chest wall invasion, and 61% and 76% for mediastinal nodal metastases. Only 19 of 45 stage III tumours were correctly identified as being stage III and resectable or unresectable. CONCLUSIONS--In patients being considered for thoracotomy for resection of lung cancer, CT scanning used as the sole method of staging is of limited value for differentiating between stage I/II and stage III tumours. Patients should not be denied the opportunity for curative surgery on the basis of equivocal CT signs.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Preoperative computed tomographic scanning for staging lung cancer.

P Armstrong
Thorax 1994 49: 941-943. [PDF]

This article has been cited by other articles:

• Vergani, C., Varoli, F., Despini, L., Harari, S., Mozzi, E., Roviaro, G. (2009). Routine surgical videothoracoscopy as the first step of the planned resection for lung cancer. J. Thorac. Cardiovasc. Surg. 138: 1206-1212 [Abstract] [Full Text]  
• Kim, B.-T., Lee, K. S., Shim, S. S., Choi, J. Y., Kwon, O J., Kim, H., Shim, Y. M., Kim, J., Kim, S. (2006). Stage T1 Non-Small Cell Lung Cancer: Preoperative Mediastinal Nodal Staging with Integrated FDG PET/CT--A Prospective Study. Radiology 241: 501-509 [Abstract] [Full Text]  
• Shim, S. S., Lee, K. S., Kim, B.-T., Chung, M. J., Lee, E. J., Han, J., Choi, J. Y., Kwon, O J., Shim, Y. M., Kim, S. (2005). Non-Small Cell Lung Cancer: Prospective Comparison of Integrated FDG PET/CT and CT Alone for Preoperative Staging. Radiology 236: 1011-1019 [Abstract] [Full Text]  
• Schroder, C., Schonhofer, B., Vogel, B. (2005). Transesophageal Echographic Determination of Aortic Invasion by Lung Cancer. Chest 127: 438-442 [Abstract] [Full Text]  
• Kelly, R. F., Tran, T., Holmstrom, A., Murar, J., Segurola, R. J. Jr (2004). Accuracy and Cost-Effectiveness of [18F]-2-Fluoro-Deoxy-D-Glucose-Positron Emission Tomography Scan in Potentially Resectable Non-small Cell Lung Cancer. Chest 125: 1413-1423 [Abstract] [Full Text]  
• Tan, B. B., Flaherty, K. R., Kazerooni, E. A., Iannettoni, M. D. (2003). The Solitary Pulmonary Nodule. Chest 123 : 89S-96S [Abstract] [Full Text]  
• Nosotti, M., Santambrogio, L., Gasparini, M., Baisi, A., Bellaviti, N., Rosso, L. (2002). Role of 99mTc-Hexakis-2-Methoxy-Isobutylisonitrile in the Diagnosis and Staging of Lung Cancer. Chest 122: 1361-1364 [Abstract] [Full Text]  
• Schaefer-Prokop, C., Prokop, M. (2002). New imaging techniques in the treatment guidelines for lung cancer. Eur Respir J 19: 71S-83s [Abstract] [Full Text]  
• Kosuda, S., Ichihara, K., Watanabe, M., Kobayashi, H., Kusano, S. (2000). Decision-Tree Sensitivity Analysis for Cost-Effectiveness of Chest 2-Fluoro-2-D-[18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Pulmonary Nodules (Non-small Cell Lung Carcinoma) in Japan. Chest 117: 346-353 [Abstract] [Full Text]  
• Dwamena, B. A., Sonnad, S. S., Angobaldo, J. O., Wahl, R. L. (1999). Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s-Meta-analytic Comparison Of PET and CT. Radiology 213: 530-536 [Abstract] [Full Text]  
• Roberts, J. R., Blum, M. G., Arildsen, R., Drinkwater, D. C. Jr, Christian, K. R., Powers, T. A., Merrill, W. H. (1999). Prospective comparison of radiologic, thoracoscopic, and pathologic staging in patients with early non-small cell lung cancer. Ann. Thorac. Surg. 68: 1154-1158 [Abstract] [Full Text]  
• M. Chan, MB, K. J., Pastorino, MD, U., Goldstraw, FRCS, P. (1999). SYSTEMATIC NODAL DISSECTION IN THE INTRATHORACIC STAGING OF PATIENTS WITH NON-SMALL CELL LUNG CANCER. J. Thorac. Cardiovasc. Surg. 117: 246-251 [Abstract] [Full Text]  
• Scott, W. J., Shepherd, J., Gambhir, S. S. (1998). Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis. Ann. Thorac. Surg. 66: 1876-1883 [Abstract] [Full Text]